Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-002500
Filing Date
2025-01-31
Accepted
2025-01-31 16:40:39
Documents
1
Period of Report
2025-01-30

Document Format Files

Seq Description Document Type Size
1 form4-01312025_090134.html 4  
1 form4-01312025_090134.xml 4 4187
  Complete submission text file 0001415889-25-002500.txt   5608
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CHIMERIX, INC., 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address
Jakeman David (Reporting) CIK: 0001780556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 25578967